Description: Data is at the core of the actuaries' role within companies, but how can actuaries translate data insights into informed and actionable decision making? The key is communicating data insights into a language that transcends analysis and enables real-time decisions that can provide an advantage to your management team. Learn an approach to choosing a tool or medium for your data insights, questions to ask yourself to better understand the communication necessary, and perspectives on how actuaries can take a larger role in actionable decisions within the industry. Understand availability, quality, and practical application of data sources health actuaries can access easily, how that data looks, approaches to transforming data into decisions, how it enriches administrative and claims data, and applications to pricing and reserving. Finally, discuss implications of ASOP 23, ASOP 41, and ASOP 56 as it relates to this topic. By attending this session, you will be able to: - Create an action plan on how to transform data into messaging for your leaders. - Use real experiences to formulate a strategy to expand the actuaries' role in informing decisions within the industry, including examples, to illustrate how data can benefit financials of health coverages. - Understand the application of ASOP 23 (Data), ASOP 41 (Communication), and ASOP 56 (Modeling) as it relates to turning data into decisions. - Be knowledgeable about new sources of morbidity for medical care and LTC and how to acquire and apply this information in actuarial models.

Description: Retirement planning generally includes a focus on decisions needed at time of retirement, but it often fails to focus on changes during retirement and additional decisions needed as people age. The 2021 SOA Risk Survey and other SOA research documents the lack of focus on future change. It is common for people to lose cognitive ability and generally to become less able to make decisions, manage their finances, their medical care and their lives at high ages.This panel focuses on communication and decision issues. The SOA has recently issued a decision guide on High Age Decisions. The brief identifies four domains for high age decisions: ·Health, health care and staying healthy ·Managing finances ·Housing and transportation ·Support networks The panel will include a discussion of communications and how we change, problems of physical, hearing, sight or cognitive decline and the challenges created and the four domains in the SOA Decision Brief.

Description: "On the decomposition of mortality models into causes of death – Andrés M Villegas Ph.D – UNSW Australia, Madhavi Bajekal, Ph.D.,HONFIA, University of London, UK, Steven Haberman, Ph.D. – Bayes Business School, University of London, UK Forecasting cause-specific mortality rates using the insights from the cointegration analysis, Séverine Arnold, PhD, Viktoriya Glushko, Department of Actuarial Science, Faculty of Business and Economics (HEC Lausanne), University of Lausanne, Switzerland"

Description: Some research implies that micro SDOH-related risk factors can influence a significant proportion of an individual's overall health outcome. Contained in SDOH are items such as mental health, ongoing social connection and interactions, transportation, financial confidence, and other items.

Description: General Session III – The Ageing Process: From New Technology to New Medicine

Description: Reference Based Pricing (RBP) efforts have increased in popularity as tools to reduce the cost of care. Now with the ability to use CMS health plan transparency information, organizations can estimate the impact of savings from the use of RBP. This session will share the results of an analysis of this in the form of a case study.

Description: A lot is happening in the annuity industry. The presenters will provide an overview of key developments in annuities and their implications to product actuaries. They will discuss recent product and market trends in fixed, indexed and variable annuities. They will also explore emerging regulatory requirements affecting annuities, such as VM-22 and Best Interest rules, as well as how they may impact product development. - Learn about recent product and market trends in annuities - Be informed of key emerging regulatory developments affecting annuities - Understand how these developments may affect product development

Description: Come discuss how to treat experience that is impacted by COVID (e.g., 2020+), as well as expected experience moving forward in terms of excess deaths related to COVID and non-COVID topics. Expect to also cover how the COVID period has impacted lapse/surrender behavior and trends in recent industry mortality and lapse studies that have been conducted including areas where individual companies typically have limited data. You will learn about various techniques of adjusting experience for the impact of COVID and the considerations in using such experience and setting a best-estimate assumption going forward. For mortality, the discussion will include both base mortality as well as future mortality improvement and the intersection of both of these.Explore an understanding of available data to supplement their experience in areas where they may have limited internal experience

Description: 2022 was a year of radical change for the annuity market as interest rates increased off historic lows. The rapid growth of RILA products stalled as FIA and MYGA products gained market share. The impacts of the higher rate environment are continuing to be realized in experience, inforce management, product design and more. Come explore the retail annuity market with a focus on the impacts of higher interest rates. Session materials will draw on experience studies, sales results, product changes, and more to examine how higher interest rates have changed the annuity market.

Description: This session will explore the mortality implications of reaching new markets, leveraging unique analysis that directly compares the mortality experience of the general populations and insured populations. Experts will explore how the industry can responsibility reduce the insurance gap, effectively employ digital data to assess new markets, and tackle the challenge with eyes wide open. At the conclusion of the session, attendees will be able to: •Understand differences in mortality experience between various populations – general, insured and uninsured •Articulate the challenges the industry may face in closing the insurance gap •Appreciate the role digital evidence can play in managing and accessing new marketing segments